MAPK11 and breast carcinoma: Upregulation of p38β in breast cancer is a prime example, p38β regulation may not have been linked to tumour growth however increased expression is associated with upregulation of monocyte chemotactic protein-1 (MCP-1) leading to osteoclast differentiation and promotion of bone metastasis in breast cancer patients [40].